Legal Frequently Asked Questions

MINDSET provides advanced neuroimaging analysis, forensic scientific consultation, and expert witness services for cases involving brain injuries and complex neurological conditions. We support legal teams, medical providers, and their clients by delivering objective, data-driven assessments of brain health—from initial record review through formal testimony—based entirely on what the science and data show.

Yes. Our role is to provide objective scientific and medical analysis, not to advocate for either side. We are retained by legal teams across the spectrum—plaintiff, defense, prosecution, and defendant—because our value lies in the accuracy and scientific rigor of our findings, not in any particular outcome.

While traumatic brain injury (TBI) represents a significant portion of our work, we support any case involving neurological conditions, including neurodegenerative diseases, acquired brain injuries, stroke-related conditions, concussion syndromes, and other complex neurological presentations. If the case involves questions of brain health, structure, or function, we can likely help.

QLuminate™ is our proprietary quantitative neuroimaging processing platform. It analyzes raw DICOM imaging files using advanced volumetric and diffusion tensor imaging (DTI) methodology and compares individual patient data against our normative database of 1,000+ healthy controls, producing objective, mathematically grounded findings on white matter integrity.

Quantify, like QLuminate, is our proprietary MRI & DTI analysis pipeline, comparing brain volume and white matter integrity in an individual brain against a cohort of age- and sex-matched control subjects. Whereas QLuminate classifies the regions of the brain according to a standard neuroradiological template, Quantify compares the brains using a map more consistent with neuropsychological assessments for easier integration with any functional assessment findings.

Our neuroimaging services include coordinating the collection of advanced MRI & DTI studies, review by licensed neuroradiologists, quantitative analysis of brain volume and white matter integrity, independent secondary reads of existing MRI and CT studies, organized integration of imaging findings in relation to additional functional assessments and symptomology, and coordination of additional imaging techniques when indicated.

A conventional MRI provides structural images of the brain and is effective at identifying major abnormalities such as bleeds, fractures, or large lesions. DTI is a more advanced MRI technique that measures the movement of water molecules along the brain's white matter fiber tracts. Because damage to axonal fibers disrupts this movement in measurable ways, DTI can identify microstructural white matter injuries that are invisible on standard imaging. This makes it particularly valuable in cases involving mild to moderate TBI, where conventional scans frequently return normal or unremarkable results despite genuine neurological injury.

Standard CT and MRI scans are optimized to detect structural damage such as fractures, hemorrhages, and swelling and are not sensitive enough to capture the microstructural axonal damage that characterizes many traumatic brain injuries, particularly mild TBI. Studies indicate that a significant proportion of individuals with documented TBI receive no TBI-related diagnosis in the emergency setting precisely because their standard imaging appears normal. This diagnostic gap is the core problem that quantitative DTI analysis is designed to address.

Fractional anisotropy is a quantitative metric derived from DTI that measures the directionality of water diffusion within white matter fiber tracts. In a healthy brain, water moves in a highly organized, directional manner along intact nerve fibers. When those fibers are damaged, diffusion becomes less organized, and FA values decrease. By comparing an individual's FA measurements against a normative database, we can objectively identify and document regions of white matter that fall outside the range of healthy controls.

Our proprietary normative database contains DTI data from 1,000+ individuals. It provides the statistical baseline against which an individual's imaging is compared, enabling objective, quantitative identification of abnormalities rather than subjective visual interpretation alone. The size, quality, and validation of a normative database is a critical factor in the scientific rigor and defensibility of any DTI-based analysis.

DTI evidence has been admitted in both federal and state courts across the country. Admissibility is evaluated under either the Daubert standard, used in federal courts and a majority of states, or the Frye standard, still followed in several states. Under Daubert, the inquiry focuses on whether the methodology is reliable, testable, peer-reviewed, and grounded in accepted scientific principles—criteria that quantitative DTI analysis, when performed rigorously, is well-positioned to satisfy. Admissibility challenges typically focus on the specifics of how the analysis was conducted, not on the science itself.

Our methodology is grounded in peer-reviewed science, employs a validated normative database, follows established volumetric and DTI processing protocols, and is interpreted by board-certified neuroradiologists with forensic experience. Our reports document the methodology transparently and completely so that opposing counsel, judges, and independent experts can evaluate exactly how findings were reached. Challenges to DTI evidence typically arise from methodological gaps, such as inconsistent scanner protocols, inadequate normative controls, or lack of quality control thresholds, which our process is specifically designed to prevent.

The most frequently raised challenges include the absence of a pre-injury baseline scan for comparison, the use of group-based normative data to draw individual-level conclusions, differences between imaging equipment used for the patient versus the control database, and the argument that DTI is not in routine clinical use. Our analysis addresses these directly through rigorous methodology, comprehensive documentation of processing parameters, a large and validated normative database harmonized to every scanner we process data from, and expert testimony from board-certified neuroradiologists who can clearly explain the scientific basis for each finding and its limitations.

No. There is no legal requirement under either Daubert or Frye that a diagnostic method be in routine clinical use for it to be admissible as the basis for expert opinion. What matters is whether the methodology is scientifically valid and reliably applied.

All neuroimaging analysis is interpreted by board-certified neuroradiologists with subspecialty expertise in brain injury imaging and forensic neuroimaging. Our experts maintain active clinical or academic practices, or both, which is an important factor in both the credibility of their opinions and their ability to withstand challenges to their qualifications.

Yes. Our neuroradiologists are experienced expert witnesses and are available for deposition testimony and trial testimony. They are prepared to clearly explain the science, the methodology, and the specific findings in terms that judges and juries can understand, and to address opposing expert challenges with precision.

Our experts provide objective scientific opinions based on the data, not based on who has retained them. The credibility of expert neuroimaging testimony depends entirely on its independence and scientific integrity, which is why our findings reflect what the data shows, regardless of how that may bear on a case.

Early engagement allows our team to conduct a thorough record review, identify whether advanced neuroimaging is clinically indicated, flag gaps in prior evaluation or treatment, and ensure the scientific foundation of the case is built correctly from the start. However, for imaging alone, it can take 9–12 months before the complete structural damage from a brain injury has fully developed, so even if it has been a year or more, we can help.

Yes. We offer an initial case assessment call to discuss the existing records and imaging and advise whether our suite of services may be helpful and scientifically applicable to the case.

We typically request existing medical records, prior imaging studies in DICOM format where available, and any relevant symptom documentation. From there, our team conducts an initial review and advises on whether additional neuroimaging or further analysis is indicated.

All case materials are submitted through our secure, HIPAA-compliant portal, designed to protect the confidentiality of client health information throughout the engagement. Alternatively, we can work to help retrieve preexisting records for you if needed.

Turnaround time depends on the volume and complexity of materials involved. We provide realistic timelines at the outset of each engagement and work with legal teams to accommodate case deadlines where possible.

Depending on the scope of engagement, deliverables may include a quantitative MRI & DTI analysis report, neuroradiological interpretation report, comprehensive medical record summaries, pre-existing conditions documentation, gap analysis findings, causation analysis, and formal expert reports suitable for court submission. Full-spectrum engagements include all applicable deliverables, while targeted engagements are scoped to the specific services retained.

We regularly work within active and tight timelines. Early engagement is strongly recommended to allow adequate time for thorough analysis, report preparation, and any necessary expert preparation prior to deposition or trial.